IDEXX Laboratories, Inc. (NASDAQ:IDXX), announced that it will participate in the Bank of America Merrill Lynch 2014 Healthcare Conference. Brian McKeon, Executive Vice President and Chief Financial Officer, is scheduled to make a presentation on the Company on Wednesday, May 14, 2014 at 5:00 p.m. PT, at the Encore at Wynn, Las Vegas, Nevada. IDEXX Laboratories, Inc. (NASDAQ:IDXX), shares after opening at $130.22 moved to $131.00 on last trade day and at the end of the day closed at $129.38. Company price to sales ratio in past twelve months was calculated as 4.72 and price to cash ratio as 23.19. IDEXX Laboratories, Inc. (NASDAQ:IDXX), showed a positive weekly performance of 2.33%.
Sunshine Health, a subsidiary of Centene Corp (NYSE:CNC), has earned a prestigious national award at the Dorland Health’s Fifth Annual Case in Point Platinum Awards in Washington, D.C. Sunshine Health won first place for its successful Long-Term Care (LTC) plan and received an honorable mention for its Transitions of Care program. Centene Corp (NYSE:CNC), shares advanced 1.57% in last trading session and ended the day on $68.56. Centene Corp (NYSE:CNC), return on equity ratio is recorded as 25.10% and its return on assets is 8.80%. Centene Corp (NYSE:CNC), yearly performance is 42.48%.
Novartis AG (ADR) (NYSE:NVS), is ready for worldwide regulatory filing forpasireotide LAR, and it got approval for Zykadia (ceritinib) from FDA for the treatment cancer. Novartis AG (ADR) (NYSE:NVS), shares moved up 0.73% in last trading session and was closed at $88.31, while trading in range of $ 87.81 – 88.35. Novartis AG (ADR) (NYSE:NVS), year to date (YTD) performance is 13.57%.
Hospira, Inc. (NYSE:HSP), realized sales of $1.05 billion, an increase of 19 percent on a year-over-year basis. The bottom-line also improved by almost a similar margin to $101 million. The company promised improved performance once it gets its two Indian facilities online and addresses problems at the Rocky Mount facility in the U.S. Hospira, Inc. (NYSE:HSP), weekly performance is 4.19%. On last trading day company shares ended up $47.72. Hospira, Inc. (NYSE:HSP), distance from 50-day simple moving average (SMA50) is 10.06%. Analysts mean target Price for the company is $43.64.